Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | Director · President & CEO | June 06, 2022 | June 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date June 06, 2022 · Filed June 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 152,415 |
Ending reported balance
After 2022-06-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2022-06-06 · Exercise / conversion · Acquired 12,886 · Balance 96,531 Row 2 · 2022-06-06 · Exercise / conversion · Acquired 34,928 · Balance 131,459 Row 3 · 2022-06-06 · Exercise / conversion · Acquired 14,765 · Balance 146,224 Row 4 · 2022-06-06 · Exercise / conversion · Acquired 6,191 · Balance 152,415 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $7.76 · Expires 2025-03-02 | Direct | 40,114 |
Reported balance
After 2022-06-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-06-06 · Exercise / conversion · Disposed 12,886 · Balance 40,114 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $7.52 · Expires 2026-03-17 | Direct | 65,072 |
Reported balance
After 2022-06-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-06-06 · Exercise / conversion · Disposed 34,928 · Balance 65,072 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2027-03-20 | Direct | 80,235 |
Reported balance
After 2022-06-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-06-06 · Exercise / conversion · Disposed 14,765 · Balance 80,235 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $16.15 · Expires 2028-03-14 | Direct | 68,809 |
Reported balance
After 2022-06-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-06-06 · Exercise / conversion · Disposed 6,191 · Balance 68,809 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2018 Filed Jun 15, 2018 01:58 UTC Amendment | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock · Derivative | 40,452 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-18-037925 · doc4a.xml · derivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,452 Underlying: Common Stock · 40,452 shares Expires 2028-06-13 F1 · security: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 20:25 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 6,667 | $16.09 | $107,272.03 |
DisclosureSEC source: 0001209191-18-021083 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,513 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 15.95 to $16.25. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 75,000 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-18-020647 · doc4.xml · derivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-03-14 F1 · security: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021. Read SEC document |
| March 21, 2017 Filed Mar 21, 2017 20:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 200,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-17-022069 · doc4.xml · derivative · entry 2 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-03-21 F1 · security: The options granted become exercisable as follows: 1/3 on 3/21/2018 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/21/2020. Read SEC document |
| March 18, 2017 Filed Mar 21, 2017 20:50 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 6,320 | $9.90 | $62,568.00 |
DisclosureSEC source: 0001209191-17-022069 · doc4.xml · nonDerivative · entry 1 Mason Caren L · CIK 0001301366 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,180 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.